Koa Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Buy
836
+3
+0.4% +$769 0.14% 52
2026
Q2
$210K Buy
+833
New +$179K 0.14% 49

Other funds holding ABBV

Koa Wealth Management's ABBV Position: Q3 2026 in Review

Koa Wealth Management increased its AbbVie (ABBV) stake by 0.36% in Q3 2026, buying an estimated $769 and bringing the position to 836 shares worth $219K. The position accounts for 0.14% of the portfolio, ranked #52.

Koa Wealth Management first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Koa Wealth Management held 836 shares of AbbVie worth $219K as of Q3 2026.
  • Koa Wealth Management bought 3 AbbVie shares in Q3 2026, an estimated $769.
  • AbbVie made up 0.14% of Koa Wealth Management's portfolio in Q3 2026, its #52 holding.
  • Koa Wealth Management first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Koa Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.